TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced ...

Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center has launched the Albert and Margaret Alkek Foundation Center for Experimental Therapeutics, a Phase 1 clinical trial program that ...

CHICAGO – During HIMSS Global Conference's Behavioral Health Forum, John MacKenzie, clinical program manager and behavioral health specialist at CommonSpirit Telehealth Network, discussed how to ...

Patients with cancer face daunting coordination problems at a vulnerable time. Lay navigation programs offer 1 approach to address these problems, but how to best implement these programs presents ...

Whether you aspire to become a Clinical Research Associate, Clinical Trial Coordinator, Regulatory Affairs Specialist, or Clinical Data Manager, our Clinical Research Certificate program will empower ...